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Abstract
Dilated cardiomyopathy (DCM) is a highly prevalent and often lethal disease in Irish wolfhounds. Complex segregation
analysis indicated different loci involved in pathogenesis. Linear fixed and mixed models were used for the genome-wide
association study. Using 106 DCM cases and 84 controls we identified one SNP significantly associated with DCM on CFA37
and five SNPs suggestively associated with DCM on CFA1, 10, 15, 21 and 17. On CFA37 MOGAT1 and ACSL3 two enzymes of
the lipid metabolism were located near the identified SNP.
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Introduction
Dilated cardiomyopathy (DCM) is a myocardial disorder which
affects dogs as well as humans. The disease is characterized by
systolic dysfunction caused by an impaired myocardial contractil-
ity and progressive dilation of the left or both ventricles. Affected
dogs often develop signs of congestive heart failure (CHF) during
the progession of the disease or die from sudden cardiac death. A
familial background for DCM has been suggested in several dog
breeds and in people [1–3].
In humans, DCM is a genetically heterogenic disease [4,5].
Rare variants of genes encoding predominantly sarcomeric,
cytoskeletal or nuclear proteins have been shown to account for
monogenic familial forms of DCM [6]. Until now, mutations in
more than 30 genes have been associated with DCM [7]. There is,
however, also some evidence that common genetic variants might
play a role for causing DCM in humans [8].
Several human candidate genes have been ruled out as
causative in Doberman Pinschers, Irish wolfhounds and New-
foundland dogs [9–18].
Recently, using mainly a linkage, candidate gene or genome-
wide association analyses evidence was found for genomic loci
being associated with cardiac diseases in dogs. In Boxer dogs from
US, a mutation in the striatin gene was found associated with
arrhythmogenic right ventricular cardiomyopathy (ARVC) but
could not explain all cases of ARVC [19]. In Portuguese
waterdogs, for a genomic region spanning 3.9 Mb on dog
chromosome 8 linkage has been demonstrated for a juvenile form
of DCM [20].
A mutation in the ACTN2 gene has been associated with DCM
in some, but not all, affected Doberman Pinschers [21]. In
addition, it has been shown that a locus on canine chromosome
(CFA) 5 was associated with DCM in Doberman Pinschers
explaining about 50 percent of DCM cases in dogs from Germany
and the United Kingdom [22].
In Irish wolfhounds, the incidence of DCM reaches approx-
imately 20 percent [23] which leads to the highest cause-specific
mortality rate for cardiac disease in the breed compared to all
other breeds [24]. The mean age of onset has been estimated at
4.5262.0 years and female dogs are less frequently affected and
develop the disease at an older age than males [23–25]. This
suggests a protective effect in female Irish wolfhounds. A major
gene model with sex-specific allele effects was the most plausible
explanation for the inheritance of DCM in Irish wolfhounds
whereas a monogenic mode of inheritance of DCM had been
rejected using complex segregation analysis [26]. Echocardio-
graphic reference values have been established for Irish
wolfhounds, facilitating the diagnosis of DCM in this breed
[27,28]. The objective of this study was to identify loci associated
with DCM in Irish wolfhounds. Therefore, we conducted a
genome-wide association study (GWAS) to identify susceptibility
loci for DCM in Irish wolfhounds.
Results
Mapping Genomic Regions
A genome-wide association study was performed for 106 Irish
wolfhound-DCM-cases and 84 Irish wolfhound-DCM-controls
using the canine Illumina high density (HD) beadchip (Illumina,
San Diego, CA, USA). The 190 Irish wolfhound samples (Table
S1) were collected in Central Europe (including samples from
Germany, The Netherlands and Belgium), France and Sweden
(including samples from Denmark and Norway). Using general
linear model analysis (GLM) with sex, inbreeding coefficient and
the first three principal components as covariates a significant
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(Figure 1, Table 1). The corresponding quantile-quantile (Q-Q)
plot illustrates the level of potential p-value inflation (Figure S1).
The error probability threshold was 9.72610
26 for DCM using
Bonferroni correction at a p-value of 0.05 for 5142 independent
tests. The assumption of 5142 independent tests was based on pair-
wise correlation coefficients among alleles for all SNPs used in
GWAS and threshold for r
2,0.2. In order to provide moderate
evidence of association a threshold of 1610
24 was used [29,30].
Applying this less stringent threshold resulted in five additional
SNPs associated with DCM on CFA1, 10, 15, 17 and 21 (Figure 1,
Table 1).
Mixed model analysis (MLM) including sex, inbreeding
coefficient and the first three principal components as covariates
confirmed the GLM analysis (Figure S2). The SNP highest
associated with DCM on CFA37 was identical in both analyses.
Due to fact that we included dogs of several countries the possible
impact of population stratification on the GWAS result was
evaluated for the first three principal components in scatter plots
(Figure S3). The results indicated that stratification probably did
not impair the association results.
In order to quantify the impact of the single SNPs on
occurrence of DCM the odds ratios (OR) were estimated. The
ORs for the single SNPs were between 1.31 for BICF2P5199741
on CFA21 and 3.62 for BICF2P801304 on CFA10.
The highest associated SNP BICF2G630134189 on CFA37 is
located about 40 kb distal to MOGAT1 and 80 kb proximal to
ACSL3. The SNPs on CFA10, 15 and 21 are located in the genes
ARGHAP8, FSTL5 and PDE3B, respectively (Table 1) while the
other two SNPs moderately associated with DCM are located in
intergenic regions (Figure S4, S5, S6, S7, S8, S9).
To identify haplotypes associated with DCM linkage disequi-
librium and haplotype block analysis was performed. Haplotype
blocks containing the SNPs associated with DCM were identified
for five chromosomes (Table S2). On CFA21, no significantly
associated hapotype block (p-value ,0.05) was observed. The size
of the associated haplotype blocks varied from 78 kb on CFA15 to
794 kb on CFA17. On CFA17, the genes SPAG17 and TBX15 are
within the associated haplotype block. On CFA37, the associated
haplotype block of 294 kb contains the genes MOGAT1 and
ACSL3.
Discussion
The genome-wide association study in Irish wolfhounds
demonstrated the potential involvement of six loci in DCM. We
identified one SNP significantly associated with DCM on CFA37
and five SNPs with evidence of association with DCM on CFA1,
10, 15, 17 and 21. The same SNPs were consistently mapped using
GLM and MLM analyses. Our results suggest that DCM in Irish
wolfhounds is not inherited as a simple Mendelian trait. This
finding is in agreement with a previous complex segregation
analysis which found an autosomal dominant major gene model
with sex-specific allelic effects as the best suited inheritance model
for DCM in Irish Wolfhounds [26]. An oligogenic inheritance of
DCM might be explained by the fact that dogs from several breeds
including Great Danes, Scottish deerhounds, Barsoi and Tibet
mastiffs were crossed with few remaining Irish wolfhounds to
conserve this breed, which at the time, was close to extinction.
This admixture may have lead to many gene variants contributing
to development of DCM in Irish wolfhound population. This is in
contrast to dog breeds with pure bred founders which are classified
as closed populations and might harbour only a limited number of
disease causing alleles.
For association study we included Irish wolfhounds originated
from several European countries. Nonetheless, dog breeds are
composed of related individuals across national boundaries.
Therefore, it is important to take population structure and
relatedness into account in models avoiding false positive
associations. For this purpose we used a compressed linear model
approach that has been proven useful in controlling for these
effects in GWAS [31]. Concomitantly, this way reduced power for
any mutation whose effects confounded with population structure.
So, we may have missed contributory loci.
For eliminating potential associations due to population
structure or relatedness we fitted the first three principal
Figure 1. Manhattan plot of the genome-wide association study for dilated cardiomyopathy in Irish wolfhounds from Europe using
a general linear model analysis. The genome-wide p-values (–log10 p-values) for the SNP effect are plotted against marker position on each
chromosome. X-axis indicates marker number. Chromosomes are differentiated by colours. Colours are given below the plot. Red line indicates
threshold value of probability for significant association with DCM. Blue line indicates threshold value of probability for suggestive association with
DCM.
doi:10.1371/journal.pone.0036691.g001
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capturing false positive association due to population structure.
Scatter plots for the first three principal components indicated only
minor stratification due to sampling from the different European
countries. Correction for multiple testing was done using
5142 SNPs which were considered as independent due to their
correlation coefficients (r
2,0.2). Using another less stringent
threshold for moderate associations compensated for reduced
power applying the compressed approach.
We identified one region significantly associated with DCM and
five putative loci. Interestingly, we did not map DCM to regions
harbouring known genes causing DCM in human. This fact might
be explained that in human monogenic familial DCM cases were
investigated. Here, causative mutations are rare in the population
but have a strong effect on the phenotype. In Irish wolfhounds,
DCM has a high incidence. Therefore, we looked for more
common variants with smaller phenotypic effects. Our findings are
supported by GWAS on ARCV in Boxers [19] and on DCM in
Doberman Pinschers [22]. In the Boxer dog, the striatin gene seems
to be causative for many ARVC cases in the United States. But the
associated mutation explained not all cases and there are also
unaffected dogs carrying the disease related mutation. Therefore,
other still unknown genes are involved in developing ARCV. For
DCM in Doberman Pinschers, one QTL on CFA5 was mapped.
However, the best associated SNP identified about 50 percent of
DCM cases in this breed. Further genomic regions were not
mapped which supports the hypothesis that other loci with smaller
effects contribute to the Doberman Pinscher DCM. Incidentally, it
is worth to mention that the genomic region observed in
Doberman Pinschers is not identical with any region mapped in
Irish wolfhounds.
In Irish wolfhounds, the SNPs contributed in different degrees
to the occurrence of DCM in Irish wolfhounds which could be
shown by their odds ratios. Indeed, these loci were not able to
explain all DCM cases in our cohort either due to incomplete
linkage disequilibrium with the causative mutations or due to
missing loci involved in DCM. There might be rare risk alleles or
alleles with small effects which did not lead to significant peaks due
to the limited numbers of diagnosed dogs. Due to inbreeding and
to a genetic bottleneck by breed foundation, Irish wolfhounds
share the longest linkage disequilibrium blocks observed in dog
populations [32]. This fact facilitated identification of DCM
associated regions but also impedes refinement of detected regions.
SNP BICF2G630134189 on CFA37 (g.31801266G.A) is the
only marker which showed significant association with DCM in
our study. It is located between MOGAT1 and ACSL3 two
enzymes of the lipid synthesis. In rats, increased mRNA
expression of ACSL3 was observed in the progression of diabetic
cardiomyopathy in the myocardium [33]. It was not shown if
the elevated expression of ACSL3 is cause or the result of the
cardiomyopathy.
On CFA10, 15 and 21 the SNPs associated with DCM are
located within genes. On CFA10, ARHGAP8 (BICF2P801304,
g.24159608A.C) is an interesting positional candidate gene. It is
a member of the RhoA activating protein family which have been
shown to regulate many aspects of intracellular actin dynamics.
Actins are components of thin filaments of (cardiac) muscle cells
and constituents of the cytoskeleton. Based on OR,
BICF2P801304 on CFA10 might have the strongest effect on
pathogenesis of DCM in Irish wolfhounds. However, the
frequency of the minor allele of 0.06 in the Irish wolfhound
population indicates only minor involvement in pathogenesis of
DCM in Irish wolfhound population.
The positional candidate gene FSTL5 (BICF2S23319191,
g.61260406A.C) on CFA15 is proposed to be a prognostic
marker for medullablastoma [34]. The gene is conserved in
human, chimpanzee, dog, rat, chicken and zebrafish but a
functional pathway has not been identified. On CFA21, PDE3B
(BICF2P5199741, g.40670543G.A) is a cGMP inhibited phos-
phodiesterase. There is evidence that PDE3B is involved in
regulation of lipolysis, lipogenesis, and insulin secretion [35]. For
ARGHAP, FSTL5 and PDE3B functional pathways need to be
elucidated more detailed. Currently, we cannot evaluate if these
genes might be involved in pathophysiology of cardiomyocytes or
if one of proximate genes may have any impact on developing
DCM in Irish wolfhounds.
On CFA1, SNP BICF2P937484 (g.123630555C.T) is associ-
ated with DCM suggesting that the nearest gene TSHZ3 located
270 kb upstream may play a role in DCM in Irish wolfhounds.
The gene is a zincfinger transcription factor which has been
associated with respiratory rhythm and breathing control [36].
But, the gene may impact regulation in other pathways. On
CFA17, four positional candidate genes GDAP2, WDR3,
SPAG17 and TBX15 are located near SNP BICF2S23232515
(g.58604566C.T). These genes have not been connected to
cardiovascular diseases. However, HMGCS2, 1.1 Mb away from
SNP BICF2S23232515 encodes a mitochondrial enzyme of the
Table 1. Summary of results for the genome-wide association study using a mixed model analysis for dilated cardiomyopathy in
European Irish wolfhounds.
Locus Position (bp) SNP Gene Major Minor MAF MAF MAF OR OR-L OR-U
-
log10P -log10P
CFA allele allele all AFF UNAFF GLM MLM
1 123,630,555 BICF2P937484 – C T 0.12 0.08 0.18 2.48 1.32 4.67 4.72 3.70
10 24,159,608 BICF2P801304 ARHGAP8 A C 0.06 0.03 0.11 3.62 1.46 9.01 4.51 3.56
15 61,260,406 BICF2S23319191 FSTL5 C A 0.26 0.22 0.32 1.63 1.03 2.59 4.02 3.64
17 58,604,566 BICF2S23232515 – C T 0.48 0.52 0.41 1.56 1.03 2.36 4.12 3.59
21 40,670,543 BICF2P5199741 PDE3B G A 0.29 0.32 0.26 1.31 1.20 2.06 4.57 4.08
37 31,801,266 BICF2G630134189 – G A 0.43 0.37 0.51 1.73 1.14 2.61 5.10
* 4.14
Identified loci on dog chromosome (CFA), position in base pair (bp), SNP identification and localization, gene name (Gene) for intragenic SNPs, major and minor allele,
the minor allele frequency (MAF) in all dogs, affected and unaffected dogs (MAF all, aff, unaff) odds ratios (OR) with lower and upper 95% confidence limits (-L, -U),
2log10 p-value of a general linear model (GLM) and mixed model analysis (MMA) is given.
doi:10.1371/journal.pone.0036691.t001
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and kidney in times of carbohydrate deprivation [37].
In total, we identified four positional candidate genes involved
in lipid metabolism (MOGAT1 and ASCL3 on CFA37, PDE3B on
CFA21 and HMGCS2 on CFA 17). Until now, no causative
mutation for DCM in genes of lipid metabolism has been reported.
However, it is known that cardiac cells use mainly fatty acids as
fuel. Between 60 to 90 percent of myocardial energy is supplied by
them. There seem to be two pathways for lipid up-take either for
VLDL-derived fatty acids or for chylomicron-derived fatty acids
[38]. Generally, the uptake of fatty acids occurs either as
lipoproteins or as free fatty acid associated with albumin. The
key enzyme for breaking down the first ones is lipoprotein lipase
(LPL). It was shown that over- or under-expression of LPL leads to
deficient hearts in mice. Increased lipid up-take led to dilated
cardiomyopathy [39]. Therefore, disturbances within pathways
connected to or involved in lipid metabolism might play a role in
developing DCM in Irish wolfhounds.
In summary, we identified one SNP significantly associated with
DCM and five loci suggestively associated with DCM in Irish
wolfhounds. The most interesting locus is located on CFA37. The
risk allele is a common variant which might impair a big part of
Irish wolfhound population.
Materials and Methods
Ethics Statement
All animal work has been conducted according to the national
and international guidelines for animal welfare. The dogs in this
study were included with consent of their owners. Data were
collected during the routine veterinary cardiologic examination for
DCM, diagnostic procedures which had to be carried out anyway.
All blood-sampling of dogs was done in veterinary clinics for small
animals by trained staff.
Animals
In total, 190 samples from Germany, The Netherlands,
Belgium, France and Sweden (the Swedish cohort includes dogs
from several Scandinavian countries) were used for analysis (Table
S1). There were 21 samples from France (19 cases and two
controls) and five Scandinavian samples (one case and four
controls). Mean age of diagnosis of all cases was 4.9 years. Dogs in
the control cohort had to be DCM unaffected and 7 years old at
diagnosis (mean age 7.7 years).
Diagnosis of DCM
DCM affected dogs had to be diagnosed by veterinary
cardiology specialists. The mean age of diagnosis was 4.9 years
for all dogs. The diagnosis of DCM was based on the results of
echocardiographic examinations. For diagnosing DCM in Irish
wolfhounds echocardiographic criteria were left ventricular
internal dimension at end-diameter systolic wider than 41 mm
and wider than 61.2 mm at end-diastole, fractional shortening
below 25%, and end-systolic volume indices greater than 41 ml/
m
2. Right ventricular dilatation was diagnosed when right
ventricular internal dimensions, measured during end-diastole,
were wider than 36.0 mm. Left or right atrial enlargement was
present when the two-dimensional systolic internal diameter of the
atrium measured parallel to the AV-valve, was wider than 56 mm
[27]. Dogs in the control cohort had to be DCM unaffected and at
least 7 years old at diagnosis (mean age 7.7 years).
DNA Extraction
Genomic DNA was extracted from EDTA blood samples
through a standard ethanol fractionation with concentrated
sodiumchloride (6 M NaCl) and sodium dodecyl sulphate (10%
SDS). Alternative, genomic DNA was extracted from buccal
samples preserved in ethanol using the NucleoSpin 96 Tissue
DNA Kit (NucleoSpin 96 Tissue DNA kit, Macherey Nagel,
Hoerdt, France) according to the manufacturer’s instructions.
Concentration of extracted DNA was determined using the
Nanodrop ND-1000 (Peqlab Biotechnology, Erlangen, Germany).
DNA concentration of samples for SNP chip analysis was adjusted
to 70–120 ng/ml.
Statistical Analysis
For genome-wide association analyses, DNA samples were
genotyped on the canine high density bead chip (Illumina, San
Diego, CA, USA) containing a total of 172,942 SNPs. Quality
criteria were minor allele frequencies (MAF) .0.05, genotyping
rate per SNP.0.90 and HWE test (p,0.00001). After filtering for
quality criteria, 83,621 SNPs remained for analysis. The mean
genotyping rate per individual was 0.995.
We performed a mixed model analysis (MMA) and a general
linear model (GLM) analysis procedure using TASSEL version
3.088 [40]. The advantage of MMA or GLM over a simplistic
approach without considering any other effects in modeling
association can be seen in removing disturbing effects caused by
data structure, different levels of relationships among animals
and inbreeding. The model included the respective SNP
genotypes, sex and inbreeding coefficients and the first three
principal components as fixed effects and the genomic
relationship matrix for the random genetic effect of the animal.
For multiple testing we used a SNP set consisting of 5142
markers due to LD between SNPs, respectively. For represent-
ing linkage disequilibrium blocks we considered a window of
20 SNPs and shifted the window 5 SNPs forward in each step.
One of a pair of SNPs was removed if the LD is greater than
0.2. The threshold of multiple tests was 9.72610
26 at 0.05 of
single test threshold. To obtain moderate evidence of association
we used a less stringent threshold of 1610
24.
For visualization and plotting of whole genome association,
haplotype block analysis and haplotype association tests and results
Haploview analysis was employed [41].
For allele frequencies of the SNPs, allele odds ratios, their
corresponding CHI square and probability values the proc allele
procedure of SAS, version 9.3 was carried out.
Supporting Information
Figure S1 Q-Q plot of general linear model using
inbreeding coefficients, sex and the first three principal
components as fixed effects. The plot compares expected
versus observed –log10 p-value for all 83,621 included in GWAS
with the grey line corresponding to the null hypothesis of no
association.
(TIF)
Figure S2 Manhattan plot of genome-wide association
study for dilated cardiomyopathy in Irish wolfhounds
from Europe using a mixed model analysis. X-axis
indicates marker number. The genome-wide p-values (–log10 p-
values) for the SNP effect are plotted against marker position on
each chromosome. Chromosomes are differentiated by colours.
Colours are given below the plot. Blue line indicates threshold
value of probability for moderate association with DCM.
(TIF)
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components. A: Principal component PC1 versus PC2 B:
Principal component PC1 versus PC3 Turquoise triangels:
Samples from Continental Europe (Germany, The Netherlands
and Belgium) Blue diamonds: Scandinavian samples (Denmark,
Norway and Sweden) Pink squares: samples from France
(TIF)
Figure S4 Genome-wide association study in 190 Euro-
pean Irish Wolfhounds showed significant association
for dilated cardiomyopathy on CFA1. (A) SNPs and their
corresponding –log10 p-values in a 1 Mb interval on dog
chromosome 1 are shown (B). Gene annotation of the highest
associated chromosomal region is shown (C). Gene annotation is
based on dog genome assembly build 2.1. Some genes are still
annotated as loc and numbers.
(TIF)
Figure S5 Genome-wide association study in 190 Euro-
pean Irish Wolfhounds showed significant association
for dilated cardiomyopathy on CFA10. (A) SNPs and their
corresponding –log10 p-values in a 0.5 Mb interval on dog
chromosome 10 are shown (B). Gene annotation of the highest
associated chromosomal region is shown (C). Gene annotation is
based on dog genome assembly build 2.1. Some genes are still
annotated as loc and numbers.
(TIF)
Figure S6 Genome-wide association study in 190 Irish
Wolfhounds from Europe showed significant association
for dilated cardiomyopathy on CFA15. (A) SNPs and their
corresponding –log10 p-values in a 1 Mb interval on dog
chromosome 15 are shown (B). Gene annotation of the highest
associated chromosomal region is shown (C). Gene annotation is
based on dog genome assembly build 2.1. Some genes are still
annotated as loc and numbers.
(TIF)
Figure S7 Genome-wide association study in 190 Irish
Wolfhounds from Europe showed significant association
for dilated cardiomyopathy on CFA17. (A) Several SNPs in a
2 Mb interval on dog chromosome 17 were suggestively associated
(B). Gene annotation of the highest associated chromosomal
region is shown (C). Gene annotation is based on dog genome
assembly build 2.1. Some genes are still annotated as loc and
numbers.
(TIF)
Figure S8 Genome-wide association study in 190 Euro-
pean Irish Wolfhounds showed significant association
for dilated cardiomyopathy on CFA21. (A) SNPs and their
corresponding –log10 p-values in a 2 Mb interval on dog
chromosome 21 are shown (B). Gene annotation of the highest
associated chromosomal region is shown (C). Gene annotation is
based on dog genome assembly build 2.1. Some genes are still
annotated as loc and numbers.
(TIF)
Figure S9 Genome-wide association study in 190 Irish
Wolfhounds from Europe showed significant association
for dilated cardiomyopathy on CFA37. (A) SNPs and their
corresponding –log10 p-values in a 3 Mb interval on dog
chromosome 37 are shown. (B). Gene annotation of the highest
associated chromosomal region is shown (C). Gene annotation is
based on dog genome assembly build 2.1. Some genes are still
annotated as loc and numbers.
(TIF)
Table S1 Irish wolfhounds used for the genome-wide
association study. Distribution by diagnosis of dilative
cardiomyopathy (DCM), sex, country of sampling and age at
diagnosis or at last examination in years (AGE) is given.
(DOC)
Table S2 Haplotype blocks associated to DCM in Irish
wolfhounds. Dog chromosome (CFA), haplotype block (bold
letters are highest associated SNPs in GLM), bold, size of
haplotype block in kb, frequency of haplotype block in all 190
Irish wolfhounds from Europe, frequency of haplotype block in
affected and control dogs, CHI square value and corresponding p-
value is given.
(DOC)
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